Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$13,122,121
+$1,386,313 QoQ
Shares Held
51,668
+7.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#952
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Frank, Rimerman Advisors LLC holds $61,050,050 across 13 Drug Manufacturers - General names. JNJ ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,066 | $13,272,893 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
51,668 | $13,122,121 | |
| 3 | ABBV |
AbbVie Inc.
|
34,526 | $8,688,122 | |
| 4 | MRK |
Merck & Co., Inc.
|
37,710 | $4,845,735 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
35,286 | $4,458,033 | |
| 6 | PFE |
Pfizer Inc
|
164,115 | $3,951,889 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
50,290 | $2,897,709 | |
| 8 | AMGN |
Amgen Inc
|
7,272 | $2,633,336 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,122,121 | 51,668 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $11,735,808 | 48,011 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $9,933,393 | 47,999 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $8,888,663 | 47,938 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $7,088,974 | 46,409 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $6,605,738 | 39,832 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,197,932 | 35,942 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,808,554 | 35,842 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $4,610,032 | 31,541 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $261,013 | 1,650 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $258,621 | 1,650 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $256,831 | 1,649 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $272,942 | 1,649 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $238,545 | 1,539 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $271,687 | 1,538 | Shares | Sole | 2023-09-07 | |
| 2022-09-30 | $251,247 | 1,538 | Shares | Sole | 2023-09-07 | |
| 2022-06-30 | $272,832 | 1,537 | Shares | Sole | 2023-09-07 | |
| 2022-03-31 | $626,862 | 3,537 | Shares | Sole | 2023-09-07 | |
| 2021-12-31 | $609,522 | 3,563 | Shares | Sole | 2023-09-07 | |
| 2021-09-30 | $244,349 | 1,513 | Shares | Sole | 2023-09-07 | |
| 2021-06-30 | $312,676 | 1,898 | Shares | Sole | 2023-09-13 | |
| 2021-03-31 | $328,864 | 2,001 | Shares | Sole | 2023-09-13 | |
| 2020-12-31 | $314,917 | 2,001 | Shares | Sole | 2023-09-13 | |
| No filing history on record for this holder in this stock. | ||||||